The German-based company, founded in 2021, has created a patented platform called HBOX (Hyperbaric Blood Oxygenation) that offers a minimally-invasive hyperoxygenation therapy device. This device delivers oxygen as a protective barrier for the lungs, benefiting patients with lung damage and pneumonia. HBOX Therapies focuses on developing technology for the lung-protective treatment of respiratory conditions.